Coverage
-
May 14, 2014
A North Carolina federal jury found Wednesday that Novartis Pharmaceutical Corp.'s failure to provide an adequate warning regarding the use of its bone drugs Zometa and Aredia didn't proximately cause a user's jaw injury, handing the company another victory in a far-reaching product liability battle over the drugs.
1 other articles on this case.
View all »